Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Comparison of Target-Controlled and Manual Total Intravenous Anesthesia in Supratentorial Surgery

NCT: NCT07357480 · RECRUITING

NCT IDNCT07357480
StatusRECRUITING
Start Date2026-01-14
Completion2026-05

Brief Summary

This study aims to investigate the effect of target-controlled infusion using the Eleveld pharmacokinetic model compared with manually controlled total intravenous anesthesia on the incidence of postoperative delirium in patients undergoing supratentorial surgery. Propofol and remifentanil are administered using either target-controlled or manual infusion techniques according to the study protocol. Secondary objectives include comparisons of intraoperative anesthetic consumption, hemodynamic responses, recovery profiles, postoperative pain, and postoperative nausea and vomiting between the two anesthesia strategies. The study seeks to evaluate whether target-controlled infusion provides improved anesthetic management and postoperative outcomes compared with manual total intravenous anesthesia.

Frequently Asked Questions

What is Comparison of Target-Controlled and Manual Total Intravenous Anesthesia in Supratentorial Surgery?

Comparison of Target-Controlled and Manual Total Intravenous Anesthesia in Supratentorial Surgery is a clinical trial registered under NCT07357480. Current status: RECRUITING.

What is the status of NCT07357480?

The current status of NCT07357480 (Comparison of Target-Controlled and Manual Total Intravenous Anesthesia in Supratentorial Surgery) is: RECRUITING.

When did Comparison of Target-Controlled and Manual Total Intravenous Anesthesia in Supratentorial Surgery start?

Comparison of Target-Controlled and Manual Total Intravenous Anesthesia in Supratentorial Surgery started on 2026-01-14.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.